DiaSorin stock rating upgraded to Outperform by RBC Capital on growth outlook

RBC Capital upgraded DiaSorin SpA (BIT:DIA) to Outperform from Sector Perform, establishing a EUR105.00 price target that suggests over 25% upside potential. The upgrade is predicated on DiaSorin's significant year-to-date underperformance and its current discounted valuation relative to peers. RBC highlights attractive mid-term growth drivers, anticipating market-leading sales growth and double-digit EBITDA/earnings CAGRs, with Q4 2026 results identified as a key catalyst for the stock.

Analysis

RBC Capital has upgraded DiaSorin SpA to Outperform from Sector Perform, establishing a EUR105.00 price target which implies over 25% upside from current levels. The upgrade is primarily justified by the stock's significant underperformance year-to-date, having fallen 17% while key peer bioMerieux has gained 22%. RBC Capital posits that this divergence has created a discounted valuation on both relative and growth-adjusted bases, presenting a compelling entry point. The firm's outlook is supported by expectations for DiaSorin to achieve market-leading sales growth and double-digit compound annual growth rates for both EBITDA and earnings over the medium term. While the Q4 results in March 2026 are cited as a key long-term catalyst, RBC also notes the potential for several unspecified 'de-risking events' in the interim that could positively influence the stock.

Key Decisions for Investors

• Given the stock's 17% year-to-date decline against a peer's 22% gain, value-oriented investors may consider the discounted valuation highlighted by RBC as an attractive entry point.
• Investors with a mid-term horizon should assess the company's potential to deliver on the forecasted double-digit EBITDA and earnings CAGRs, as this is central to the bull thesis.
• The primary catalyst is noted as Q4 2026 results, so a long-term perspective is required; investors should monitor for the unspecified interim 'de-risking events' which could provide earlier validation of the investment case.